We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
758 result(s) found, displaying 476 to 500
-
Scheduling decisions (final)Delegate-only final decisions and reasons for New Chemical Entities (NCEs) - 1 October 2019 implementation date
-
Meeting statementsThe TGA hosted a stakeholder forum in Melbourne on 10 October 2018
-
Corporate reportsThe TGA thanks respondents who provided submissions
-
Scheduling submissionsPublic submissions in response to the June 2019 ACMS/ACCS/Joint meetings
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 10 October 2019
-
Meeting statementsAdvisory Committee on Medicines
-
Corporate reportsProfessor McMillan's Final Report on the Review of the Act was tabled in Parliament on Thursday 5 September 2019
-
TGA laboratory testing reportsThis testing project was designed to assess compliance with the new Standard
-
Corporate reportsBreast implant consumer fact sheet published
-
Corporate reportsSummary of our actions following the 2018 TGA stakeholder survey
-
Scheduling decisions (final)Notice of final decisions on amendments to the Poison Standard in relation to substances considered at ACMS #26, ACCS #24, Joint ACMS-ACCS #21 (March 2019) and delegate only decisions.
-
Corporate reportsYou can help by sharing our messages on social media, your website and around your workplace.
-
Corporate reportsSubmissions received on the Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia have been published.
-
Scheduling submissionsPublic submissions in response to the March 2019 ACMS/ACCS/Joint interim decision
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Scheduling submissionsOutcomes of the public consultation on Appendix M of the Poisons Standard are now available
-
-
Meeting statementsCommunique from the third meeting of the TGACC
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Scheduling decisions (final)Final decision on the scheduling of alkyl nitrites - a matter which was most recently referred to the March 2019 Joint Advisory Committees on Medicines and Chemicals Scheduling (Joint ACMS-ACCS#21).
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 4 July 2019